Development and validation of a stability indicating HPLC method for the analysis of lornoxicam in powder for injection

Pakistan Journal of Pharmaceutical Sciences

Volumn 25, Issue 2, 2012, Pages 371-375

  Zhang, Jianjun ^a   Li, Li ^b   Gao, Yuan ^a   Fan, Weiming ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Zhejiang Zhenyuan Pharmaceutical Co Ltd   (China)

Author keywords

HPLC; Lornoxicam; Stability indicating

Indexed keywords

ACETIC ACID; ACID; BASE; LORNOXICAM; METHANOL;

ARTICLE; DRUG FORMULATION; DRUG STABILITY; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INJECTION; LIGHT; OXIDATION; PH; POWDER; QUALITY CONTROL; TEMPERATURE; VALIDATION STUDY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; INJECTIONS; LIMIT OF DETECTION; PIROXICAM; POWDERS;

EID: 84860638197     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Balfour JA, Fitton A and Barradell LB (1996). Lornoxicam: A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs, 51: 639-657.
2. Bareggi SR, Gambaro V, Valenti M and Benvenuti C (1997). Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tablets. Arzneimittelforschung, 47: 755-757.
3. Bozal B and Uslu B (2010). Applications of carbon based electrodes for voltammetric determination of lornoxicam in pharmaceutical dosage form and human serum. Comb. Chem. High Throughput Screen, 13: 598-609.
4. Hitzenberger G, Radhofer-Welte S, Takacs F and Rosenow D (1990). Pharmacokinetics of lornoxicam in man. Postgrad. Med. J., 66(Suppl 4): S22-S27.
5. Radhofer-Welte S and Dittrich P (1998). Determination of the novel non-steroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid. J. Chromatogr. B Biomed. Sci. Appl., 707: 151-159.
6. Radhofer-Welte S and Rabasseda X (2000). Lornoxicam, a new potent NSAID with an improved tolerability profile. Drugs Today, 36: 55-76.
7. Suwa T, Urano H, Shinohara Y and Kokatsu J (1993). Simultaneous high-performance liquid chromatographic determination of lornoxicam and its 5′-hydroxy metabolite in human plasma using electrochemical detection. J. Chromatogr. B. Biomed. Appl., 617: 105-110.